For a company that has 35,000 employees and is entirely dedicated to printing technologies, Dai Nippon Printing (DNP) has not been overly outspoken about its interest in 3D printing, making no clear mention of it 
The entire project revolves around the possibility of capturing the 3D data in a way that allows for 3D printing only of the necessary parts of the organs to be operated on. “For example, a doctor can print out a tumor inside the pancreas and blood veins surrounding it, without recreating the entire organ,” a spokeswoman at Dai Nippon Printing said, 
It would seem logical – although there is no direct reference to this in the report – that such an approach could implement single material SLS technology, as well, with a drastic reduction in the cost of materials (albeit, an increment in the cost of the machine).
This particular method for digital fabrication of medical models is now patent pending and is being presented at the 70th Meeting of the Japanese Gastroenterological Association taking place on July 15th through the 17th. The final chapter in the book of medical 3D printing is far from being written. Now, the more direct involvement of huge companies such as DNP shows that there is still a lot more to come.
